Cometriq

Cometriq (Cabozantinib) is an oral medication used to manage certain types of cancer. This pharmaceutical is designed to target specific proteins involved in tumor growth and spread.

Cometriq is primarily used in the treatment of advanced thyroid cancer and other specific types of cancer. It works by inhibiting the activity of proteins that contribute to the growth and spread of cancer cells. Patients often wonder, 'What is Cometriq used for?' and the answer lies in its role in managing advanced cancers where other treatments may not be effective.

Common effects of Cometriq may include fatigue, diarrhea, and nausea. Some users also experience changes in taste, loss of appetite, and high blood pressure. These effects can vary from person to person and may not affect everyone who takes the medication.

Cometriq should be handled with care and stored as directed. It is important to follow the advice of a healthcare professional regarding its use. Patients should be aware of potential side effects and discuss any concerns with their healthcare provider.

Cometriq may interact with certain medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also interact with Cometriq, so it is important to discuss lifestyle factors with your healthcare provider.